跳至主要内容
临床试验/CTRI/2024/08/072148
CTRI/2024/08/072148尚未招募2/3 期

A Comparative clinical study on the efficacy of Bhoomyamlaki Churna and Chandana Churna in the management of Asrigdara w.s.r to Menorrhagia and Metrorrhagia

Mansarovar Ayurvedic Medical College Hospital and Research Centre1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年8月20日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Duration of Menstrual Bleeding

研究概览

简要总结

The prevalence of heavy menstrual bleeding in women of reproductive age is 37.9%. Quality of life (QOL) of women with these disorders is compromised. Asrigdara is the common gynecological problem affecting her day to day activities. This leads to other diseases like anemia etc. Bhoomyamlaki Churna and Chandana Churna formulation has been selected to study the efficacy of both drug in the management of asrigdara. The aim of this study is to establish an cost effective , harmless Ayurvedic medication for the treatment of Asrigdara

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • The patients having classical symptoms of Asrigdara as per the classical references will be selected.

排除标准

  • Patients giving history of recent delivery or abortion.
  • Patients having infections such as candidiasis, trichomonaliasis or any other form of vulvo-vaginitis and pelvic congestion.
  • Patients having systemic and other disorders like Diabetes, TB, Hypertension etc.
  • will be excluded from the study.
  • Patients taking oral contraceptive pills.

结局指标

主要结局

Duration of Menstrual Bleeding

时间窗: 120 days

Interval between 2 menstrual cycle

时间窗: 120 days

Vedana

时间窗: 120 days

次要结局

  • CBC(BT CT)

研究者

发起方
Mansarovar Ayurvedic Medical College Hospital and Research Centre
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Yashi Joshi

Mansarovar Ayurvedic Medical College Hospital and Research Centre

研究点 (1)

Loading locations...

相似试验